E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor.

Cited by (7)

Abstract
Background: Adverse drug reactions (ADRs) constitute important cause of morbidity and mortality affecting all age groups. Most of the studies in past have explored and reported knowledge and perception toward ADRs among health-care professionals, pharmacists, and medical students. But studies on awareness among patients are limited. To improve understanding of ADR and its reporting, it is important to find out the same among patients.

Objective: To assess knowledge and perception toward ADR among patients visiting tertiary-care rural hospital, and to sensitize patients on ADR reporting system.

Materials and Methods: This observational study was conducted at tertiary-care teaching hospital and 150 patients were selected randomly. Demographic details of respondents were noted and questionnaire regarding knowledge and perceptions was given to fill up. Data were analyzed by using descriptive statistics.

Result: Demographic analysis showed that 59% patients were men, 56% were from rural areas, and 45% were graduates. Regarding knowledge about ADR, 78.6% patients were aware that medicines can cause ADRs and 33% had experienced side effects in past. None of the respondents were aware of ADR reporting center. Regarding perceptions toward ADR, 86.7% agreed to report ADR in future and 56% respondents believed ADR reporting may strengthen the patient safety. According to 70% patients, awareness campaign is the best way to educate them regarding ADR.

Conclusion: Educational interventions are needed to improve awareness among patients regarding importance of ADR reporting.

Key words: Knowledge; Perception; Adverse Drug Reactions


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Anuradha Joshi
Articles by Nishal Shah
Articles by Malkesh Mistry
Articles by Alpa Gor
on Google
on Google Scholar


REFERENCES
1. Tripathi KD. Essentials of Medical Pharmacology 7th edn. New Delhi: Jaypee Brothers, 2013. p. 82.
2. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4(2):e4439. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
3. Wester K, Jonnson AK, Sigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65:573-9. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15-19. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
5. Pharmacovigilance Programme of India (PvPI). PvPI: About PvPI. Available at: http://www.ipc.gov.in/PvPI/pv_about.html (last accessed on January 9, 2015).
6. World Health Organization. WHO: Pharmacovigilance. Available at: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/ pharmvigi/en/ (last accessed on January 9, 2015).
7. Pharmacovigilance Programme of India (PvPI). PvPI: ADR Reporting: List of New ADR Monitoring Centres. Available at: http://www. ipc.gov.in/PvPI/60-AMC%20new%20.pdf (last accessed on January 9, 2015).
8. Jha N, Bajracharya O, Shrestha R, Thapa HS, Shankar PR. Starting a pharmacovigilance program within a teaching hospital: challenges and experiences from Lalitpur, Nepal. South Med Rev. 2009;2(1): 7-10. [Pubmed]    [PMC Free Fulltext]   
9. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19-31. [DOI via Crossref]    [Pubmed]   
10. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
11. Bhatia A, Kapoor U, Tayal G. A survey of issues regarding ADR and ADR reporting amongst doctors in Delhi. Int J Risk Saf Med. 2005;17:30-46.
12. Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in south India. Perspect Clin Res. 2015;6(1):45-52. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
13. Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers. Natl Med J India. 2002;15:24-6. [Pubmed]   
14. Jha N, Ratthore DS, Shankar PR, Gyawali S. Pharmacovigilance knowledge among patients at a teaching hospital in Lalitpur district, Nepal. J Clin Diagn Res. 2014;8(3):32-4. [DOI via Crossref]   
15. Elkalmi R, Hassali MA, Al-Lela OQ, Jawad Awadh AI, Al-Shami AK, Jamshed SQ. Adverse drug reactions reporting: knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013;5(3):224-8. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
16. Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243-8. [DOI via Crossref]    [Pubmed]   
17. Ahmed AM, Izham IM, Subish P. Importance of consumer pharmacovigilance system in developing countries: a case of Malaysia. J Clin Diagn Res. 2010;4(4):2929-35.
18. Palaian S, Alshakka M, Izham M. Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance. Pharm World Sci. 2010;32(1):2-6. [DOI via Crossref]    [Pubmed]   
19. Indian Pharmacopoeia Commission (IPC). Medicines Side Effect Reporting Form (For Consumers). Available at: http://ipc.nic. in/writereaddata/linkimages/Part%202%20of%20Appendix% 2017%20ADR%20Reporting%20Form%20for%20Consumers% 20-1460554002.pdf (last accessed on February 12, 2015).
20. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2006;63(2):148-56. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
21. Fleuranceau-Morel P. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers. Pharmacoepidemiol Drug Saf. 2002;11:37-44. [DOI via Crossref]    [Pubmed]   
22. Potharaju HR. Reporting of adverse drug reactions by consumers: rationale and potential. Pharmbit. 2010;22(2):14-21.
23. US Food and Drug Administration. Direct Reporting by Consumers—First International Conference. WHO Pharmaceutical Newsletters [online]. Available at: www.fda.gov/medwatch/safety/ ar95.pdf.
24. Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):1-234. [DOI via Crossref]    [Pubmed]   

This Article Cited By the following articles

Parental reporting of adverse drug reactions in South Africa: An online survey
African Journal of Primary Health Care & Family Medicine 2021; 13(1): .

1
 
An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital
Medical Journal Armed Forces India 2020; 76(4): 425.

2
 
An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital
Medical Journal Armed Forces India 2019; (): .

3
 
Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study
PLoS ONE 2019; 14(11): e0225585.

4
 
Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study
BMJ Open 2019; 9(3): e027321.

5
 
A cross-sectional survey to assess the knowledge, attitudes and common barriers to the reporting of adverse drug reactions by the general public in Malaysia
J Pharm Pract Res 2018; (): .

6
 
Public awareness of adverse drug reaction medical safety
International J Health Care QA 2018; 31(6): 520.

7
 
How to Cite this Article
Pubmed Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol. 2015; 5(4): 280-284. doi:10.5455/njppp.2015.5.2502201543


Web Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. https://www.njppp.com/?mno=181071 [Access: December 01, 2022]. doi:10.5455/njppp.2015.5.2502201543


AMA (American Medical Association) Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol. 2015; 5(4): 280-284. doi:10.5455/njppp.2015.5.2502201543



Vancouver/ICMJE Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol. (2015), [cited December 01, 2022]; 5(4): 280-284. doi:10.5455/njppp.2015.5.2502201543



Harvard Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor (2015) Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. Natl J Physiol Pharm Pharmacol, 5 (4), 280-284. doi:10.5455/njppp.2015.5.2502201543



Turabian Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. 2015. Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 5 (4), 280-284. doi:10.5455/njppp.2015.5.2502201543



Chicago Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. "Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 5 (2015), 280-284. doi:10.5455/njppp.2015.5.2502201543



MLA (The Modern Language Association) Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor. "Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 5.4 (2015), 280-284. Print. doi:10.5455/njppp.2015.5.2502201543



APA (American Psychological Association) Style

Anuradha Joshi, Nishal Shah, Malkesh Mistry, Alpa Gor (2015) Evaluation of knowledge and perception toward adverse drug reactions among patients visiting tertiary-care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 5 (4), 280-284. doi:10.5455/njppp.2015.5.2502201543